News

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...
China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...
Western drugmakers, investors increasingly aim to acquire Chinese compounds.
70. If the last few months are any guide, there will be no shortage of surprises and challenges for the biotech industry in the new year. Donald Trump will begin his second term, possibly bringing ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...
MassBio, a trade group for the biotech industry, issued an “industry snapshot” last week that said Massachusetts continued to expand its biopharma workforce in research labs and manufacturing ...
The Biotech industry has underperformed due to the Trump administration, RFK Jr.'s skepticism, and funding uncertainty, with major ETFs down 19-25% over six months. Some biotech companies with ...
The biotech industry’s DeepSeek moment came last fall. That is when Summit Therapeutics, backed by billionaire Bob Duggan, ...
Private biotech startups raised $5.1 billion in ... Tellingly, MassBio’s 2022 Industry Snapshot shows that biopharma jobs grew by 13.2 percent last year, with 12,400 employees added to a total ...
Karen lives in Wakefield with her three children, husband and dog, Marty McFly. Mark Herz: Massachusetts is a hub for biotech. According to the 2023 mass bio industry snapshot, biopharma accounted for ...
Massachusetts is a hub for biotech: According to the latest MassBio industry snapshot, biopharma accounted for more than 15% of job growth in the entire state in 2023. This month, we’re hearing from ...